Enthera Pharmaceuticals
Phase 1Developing the first disease-modifying treatment for severe autoimmune disorders.
Founded
2016
Focus
AntibodiesBiologics
About
Developing the first disease-modifying treatment for severe autoimmune disorders.
Funding History
2Total raised: $97M
Series B$56MNovartis Venture FundJan 15, 2022
Series A$41MSofinnova PartnersJan 15, 2020
Company Info
TypePrivate
Founded2016
LocationMilan, Italy
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile